Live bacterial therapeutics for detection and treatment of colorectal cancer.
暂无分享，去创建一个
[1] Tal Danino,et al. Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia , 2024, Nature Communications.
[2] J. Hasty,et al. Engineered bacteria detect tumor DNA , 2023, Science.
[3] J. Hasty,et al. Intestinal transgene delivery with native E. coli chassis allows persistent physiological changes , 2021, Cell.
[4] W. Makarewicz,et al. Therapeutic methods of gut microbiota modification in colorectal cancer management – fecal microbiota transplantation, prebiotics, probiotics, and synbiotics , 2020, Gut microbes.
[5] Tal Danino,et al. Programmable bacteria induce durable tumor regression and systemic antitumor immunity , 2019, Nature Medicine.
[6] R. Evans,et al. FXR Regulates Intestinal Cancer Stem Cell Proliferation , 2019, Cell.
[7] B. Helmink,et al. Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis , 2018, Nature Medicine.
[8] Laurence Zitvogel,et al. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors , 2018, Science.
[9] M. Omar Din,et al. Synchronized cycles of bacterial lysis for in vivo delivery , 2016, Nature.